Home NDC 42291-476-60 Lubiprostone
Product NDC 42291-476
Requested package NDC 42291-476-60
11-digit product format 422910476
Labeler code 42291
Product ID 42291-476_f1763c5a-5f35-fac0-e053-2995a90a038a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lubiprostone
Dosage form CAPSULE
Route ORAL
Labeler AvKARE
Application ANDA209450
Marketing category ANDA
Marketing start 2023-01-04
Marketing end 0000-00-00
Substance LUBIPROSTONE
Active strength 24 ug/1
Pharmacologic classes Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]
NDC exclude flag No
Listing certified through 2024-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209450-001 LUBIPROSTONE LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 A209450-002 LUBIPROSTONE LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 66 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL 2021-11-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL 2021-11-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL 2021-11-30 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL 2021-11-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 782e0a99824c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 6a51e52b5d6a…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 52 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42291-476-60 Lubiprostone 60 in 1 BOTTLE CAPSULE 60 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42291-476 LUBIPROSTONE CAPSULE [AVKARE] 2 Legacy NDC, 1 package rows 20230325_f1763c5a-5f36-fac0-e053-2995a90a038a.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 42291-476-60 42291047660 60 CAPSULE in 1 BOTTLE (42291-476-60) 60 capsule 2023-01-04 0000-00-00 No No Current